Estrogen Receptor Antagonists

Name
Estrogen Receptor Antagonists
Accession Number
DBCAT001199
Description

Compounds and drugs that bind to and block or inhibit the activation of ESTROGEN RECEPTORS.

Drugs
DrugDrug Description
FulvestrantAn estrogen receptor antagonist used to treat HR+ breast cancer that may also be HER2-.
ElacestrantAn estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.
Drugs & Drug Targets
DrugTargetType
FulvestrantEstrogen receptor alphatarget
FulvestrantCytochrome P450 3A4enzyme
FulvestrantUDP-glucuronosyltransferase 1-1enzyme
ElacestrantEstrogen receptor alphatarget
ElacestrantCytochrome P450 3A4enzyme
ElacestrantCytochrome P450 2A6enzyme
ElacestrantCytochrome P450 2C9enzyme
ElacestrantSolute carrier organic anion transporter family member 2B1transporter
ElacestrantP-glycoprotein 1transporter
ElacestrantATP-binding cassette sub-family G member 2transporter